Neoadjuvant Therapy in Pancreatic Cancer: An Emerging Strategy

Pancreatic adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths among men and women, being responsible for 6% of all cancer-related deaths. Surgical resection offers the only chance of cure, but only 15 to 20 percent of cases are potentially resectable at presentation. In recent years,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bittoni, Alessandro, Santoni, Matteo, Lanese, Andrea, Pellei, Chiara, Andrikou, Kalliopi, Stefano, Cascinu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101999/
https://www.ncbi.nlm.nih.gov/pubmed/25101123
http://dx.doi.org/10.1155/2014/183852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101999/
https://www.ncbi.nlm.nih.gov/pubmed/25101123
http://dx.doi.org/10.1155/2014/183852

Ejemplares similares